Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression
| Status: | Completed |
|---|---|
| Conditions: | Depression, Psychiatric, Bipolar Disorder |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/19/2018 |
| Start Date: | February 2015 |
| End Date: | March 31, 2018 |
The purpose of this study is to determine if a mobile sensing platform can passively and
objectively detect the presence of clinically significant mood disorder symptomatology and
symptom progression over time. Meeting this goal will allow for improved risk categorization,
prediction of relapse, and measurement of disease progression in a lifetime prevalence
population.
objectively detect the presence of clinically significant mood disorder symptomatology and
symptom progression over time. Meeting this goal will allow for improved risk categorization,
prediction of relapse, and measurement of disease progression in a lifetime prevalence
population.
Inclusion Criteria:
- Age 18 or older
- Have a smartphone and cell service plan, including voice and data, that meets the
device requirements of the Mobile Sensing Platform.
- Enrolled in the MoodNetwork
Exclusion Criteria:
- Report positively on the QIDS-SR suicide item during study intake
- Total score greater than 15 on the QIDS-SR during the screening process
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Thilo Deckersbach, PhD
Phone: 617-643-2076
Click here to add this to my saved trials
